Skip to Content
US Videos

Putting LabCorp Under the Microscope

Will recent legislation affect its 2021?


Debbie Wang: We've been taking another look at LabCorp because this company is slightly undervalued and it has been under a lot of reimbursement pressure from Medicare, thanks to a new market-based reimbursement system that was heavily skewed towards the lowest-cost producers including LabCorp and Quest. Now we're seeing the diagnostic lab industry fighting back, and they have convinced Medicare to include more of the high-cost, hospital-based labs as we go into the next reset of these reimbursement rates. Most recently, we have seen bipartisan legislation come out of the House that would allow for more time for these hospital-based labs to comply with the onerous reporting requirements. In the end, we think that this will lead to higher reimbursement rates for Medicare going into 2021.

Debbie Wang does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.